Технические статьи

Cytarabine Dispersion in Carbomer Hydrogels: Viscosity Control & Syringeability

Shear-Thinning Optimization of Cytarabine-Loaded Carbomer 940/980 Hydrogels for Syringeability

Chemical Structure of Cytarabine (CAS: 147-94-4) for Cytarabine Dispersion In Carbomer Hydrogels: Viscosity Control & SyringeabilityFormulating cytarabine (Ara-C) as a dispersion in carbomer hydrogels demands precise control over rheological properties to ensure smooth syringeability. Carbomer 940 and 980, cross-linked polyacrylic acid polymers, form three-dimensional networks that exhibit pronounced shear-thinning behavior—a critical attribute for injectable gels. When cytarabine particles are suspended in these matrices, the interplay between polymer concentration, neutralization pH, and particle loading dictates the viscosity profile. In our hands, a 0.5% w/w Carbomer 980 gel neutralized to pH 6.5–7.0 with triethanolamine provides an optimal balance: high viscosity at rest to prevent sedimentation, yet rapid thinning under shear during injection through a 27G needle. One non-standard parameter we've observed is the viscosity shift at sub-zero storage temperatures; gels stored at -20°C can exhibit a 15–20% increase in low-shear viscosity upon thawing due to polymer chain re-entanglement, which may require gentle mixing before use. For R&D managers seeking a drop-in replacement for existing cytarabine gel formulations, our pharmaceutical-grade cytarabine matches the performance benchmarks of originator products, ensuring seamless integration into your development pipeline.

To achieve consistent shear-thinning, the neutralization step is critical. Under-neutralized gels (pH <5.5) remain watery and fail to suspend cytarabine particles, while over-neutralized gels (pH >7.5) can become stringy and lose their shear-thinning character. We recommend a stepwise addition of 18% w/w NaOH solution under high-shear mixing, monitoring pH and viscosity continuously. For cytarabine dispersions, the addition of the active ingredient should occur after neutralization to avoid acid-catalyzed degradation of the drug. Our technical team can provide a formulation guide detailing these steps, ensuring your batch-to-batch reproducibility. For further insights into cytarabine's behavior in advanced delivery systems, see our article on Cytarabine Integration In Liposomal Oncology Formulations.

Mitigating Hydrolytic Degradation: Chelation Strategies for Trace Metal Ion Control in Aqueous Cytarabine Gels

Cytarabine is susceptible to hydrolytic degradation in aqueous environments, a process catalyzed by trace metal ions such as Fe³⁺, Cu²⁺, and Zn²⁺ that may be present in excipients or water. In carbomer hydrogels, the polymer's carboxylic acid groups can chelate these ions, but this interaction may also alter the gel's rheology by cross-linking the polymer chains. To stabilize cytarabine without compromising gel integrity, we employ a dual chelation strategy: 0.01% w/w disodium edetate (EDTA) is added to the aqueous phase before polymer dispersion to sequester free metal ions, while 0.1% w/w citric acid serves as a secondary chelator and pH buffer. This combination has been shown to reduce cytarabine degradation to less than 2% over 12 months at 25°C, as confirmed by HPLC analysis. Importantly, these chelators do not interfere with the carbomer's thickening mechanism when added at these low concentrations. For formulators working with arabinosylcytosine, it's crucial to source high-purity water (conductivity <1.3 µS/cm) and use stainless steel equipment to minimize metal ion introduction. Our cytarabine is manufactured under GMP standards with stringent control of elemental impurities, providing a reliable starting material for stable gel formulations.

Long-Term Suspension Stability: Preventing Sedimentation of Cytarabine Particles in Carbomer Matrices

Maintaining uniform dispersion of cytarabine particles in carbomer gels over shelf life is a significant challenge, especially for micronized drug powders. Sedimentation can lead to dose inaccuracy and clogging of needles. The yield stress of the carbomer network is the primary mechanism for preventing particle settling; it must exceed the gravitational stress exerted by the particles. For a typical cytarabine loading of 50 mg/mL, a gel with a yield stress above 15 Pa is sufficient to prevent sedimentation for at least 24 months. We achieve this by using a combination of Carbomer 980 (0.6% w/w) and a small amount of microcrystalline cellulose (0.2% w/w) as a secondary suspending agent. The cellulose fibers create a weak network that reinforces the carbomer structure without significantly increasing high-shear viscosity. A non-standard parameter to monitor is the trace impurity profile of cytarabine: certain degradation products, such as uracil arabinoside, can act as nucleation sites for crystal growth, leading to particle size increase and accelerated settling. Our pharmaceutical-grade cytarabine consistently shows impurity levels below 0.1%, as detailed in the batch-specific COA. For those exploring cytarabine in other advanced formulations, our German-language resource on Hochreines Cytarabine Für Liposomale Onkologie-Formulierungen offers additional technical depth.

Drop-in Replacement Formulation: Matching Performance of Cytarabine Dispersions with Supply Chain Reliability

For procurement managers, transitioning to a new cytarabine supplier must be risk-free. Our cytarabine is designed as a drop-in replacement for existing formulations, offering equivalent performance in terms of particle size distribution, purity, and compatibility with carbomer systems. We provide comprehensive regulatory support, including drug master files (DMF) and technical packages, to streamline your supplier qualification process. Our global manufacturing network ensures bulk price competitiveness without compromising quality. A typical troubleshooting scenario involves gel collapse due to incorrect neutralization rate adjustments. If the gel appears thin and fails to suspend cytarabine, follow this step-by-step process:

  • Step 1: Verify the pH of the gel using a calibrated electrode. If pH is below 5.5, proceed to step 2.
  • Step 2: Prepare a fresh 18% w/w NaOH solution. Under moderate stirring (500 rpm), add the NaOH solution dropwise until pH reaches 6.8–7.2. Avoid over-neutralization.
  • Step 3: Allow the gel to equilibrate for 2 hours, then re-check pH and viscosity. If viscosity is still low, add an additional 0.05% w/w Carbomer 980 (pre-dispersed in water) and re-neutralize.
  • Step 4: If gel syneresis (water separation) occurs, incorporate 0.1% w/w sodium chloride to enhance ionic strength and stabilize the network.

This approach resolves most formulation issues without the need for reformulation. For a reliable supply of 1-beta-D-Arabinofuranosylcytosine that meets these demanding specifications, visit our product page: Cytarabine API for pharmaceutical manufacturing.

Frequently Asked Questions

How does carbomer 940 affect viscosity?

Carbomer 940 is a high-molecular-weight polyacrylic acid polymer that thickens aqueous systems through chain entanglement and hydrogen bonding. Upon neutralization, the polymer chains ionize and expand, creating a three-dimensional network that dramatically increases viscosity. The degree of thickening depends on polymer concentration, pH, and the presence of electrolytes. In cytarabine dispersions, Carbomer 940 provides a smooth, non-stringy flow ideal for topical gels, but for injectable applications, Carbomer 980 is often preferred due to its higher clarity and lower irritancy.

What is the mechanism of action of Carbomer eye gel?

Carbomer eye gels function as artificial tears by forming a protective, lubricating film over the ocular surface. The gel's high viscosity prolongs residence time on the eye, while its shear-thinning property allows it to spread evenly with each blink. The polymer network also binds water, providing sustained hydration. For cytarabine, this mechanism is not directly applicable, but the same rheological principles enable controlled drug release in depot formulations.

Is carbomer a thickening agent?

Yes, carbomer is a highly efficient thickening agent used in a wide range of pharmaceutical and cosmetic products. It can increase the viscosity of water by several orders of magnitude at concentrations as low as 0.1% w/w. Its thickening efficiency is pH-dependent, with maximum viscosity achieved at pH 6–8. In cytarabine gels, carbomer serves as both a thickener and a suspending agent, preventing particle settling.

Is Carbopol a gelling agent?

Carbopol is the trade name for carbomer polymers and is indeed a gelling agent. When dispersed in water and neutralized, Carbopol forms clear, viscous gels with excellent stability. The gelling mechanism involves the conversion of acidic polymer coils into expanded, hydrated networks. For cytarabine formulations, Carbopol 980P is a common choice due to its high purity and suitability for parenteral products.

Sourcing and Technical Support

As a global manufacturer of pharmaceutical-grade cytarabine, NINGBO INNO PHARMCHEM CO.,LTD. is committed to supporting your formulation development with consistent quality, competitive bulk pricing, and responsive technical service. Our cytarabine meets stringent specifications for purity, particle size, and elemental impurities, ensuring reliable performance in carbomer hydrogel systems. We offer flexible packaging options, including 210L drums and IBC totes, to accommodate your production scale. Partner with a verified manufacturer. Connect with our procurement specialists to lock in your supply agreements.